| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 8Y1PJ3VG81 |
| InChI Key | XPRDUGXOWVXZLL-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H18FNO4 |
| Molecular Weight | 355.37 |
| AlogP | 4.0 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 75.63 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 26.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
2754-2800 | 134-134 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Inflammatory Bowel Diseases | 2 | D015212 | ClinicalTrials |
| Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
| Cholangitis, Sclerosing | 2 | D015209 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL197194 |
| DrugBank | DB15446 |
| EPA CompTox | DTXSID50431325 |
| FDA SRS | 8Y1PJ3VG81 |
| Guide to Pharmacology | 9860 |
| PDB | D5H |
| PubChem | 9820008 |
| SureChEMBL | SCHEMBL247888 |
| ZINC | ZINC000014960644 |